Clonidine impairs sustained attention and memory in Alzheimer's disease

Neuroscience

Volumn 92, Issue 3, 1999, Pages 975-982

  Riekkinen, M ^a   Laakso, M P ^a   Jakala P ^a   Riekkinen Jr, P ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adrenergic alpha 2 agonist pharmacology; Alpha 2 drug effects; Alpha 2 receptors; Attention drug effects; Clonidine pharmacology; Noradrenaline pharmacology

Indexed keywords

CLONIDINE;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MOTOR PERFORMANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPATIAL MEMORY; VISUAL MEMORY;

ADRENERGIC ALPHA-AGONISTS; AGED; ALZHEIMER DISEASE; ATTENTION; BLOOD PRESSURE; CHOICE BEHAVIOR; CLONIDINE; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; REACTION TIME;

EID: 0033036871     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00070-6     Document Type: Article

References (37)

1. Aghajanian G.K. Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. Essays Neurochem. Neuropharmac. 3:1978;1-32.
2. Aghajanian G.K., Cedarbaum J.M., Wang R.Y. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res. 136:1977;570-577.
3. Arnsten A.F. Catecholamine mechanisms in age-related cognitive decline. Neurobiol. Aging. 14:1993;639-641.
4. Arnsten A.F., Steere J.C., Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Archs gen. Psychiat. 53:1996;448-455.
5. Bergles D.E., Van Doze A., Madison D.V., Smith S.J. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J. Neurosci. 15:1996;572-585.
6. Bijak M., Misgeld U. Adrenergic modulation of hilar neuron activity and granule cell inhibiton in the guinea-pig hippocampal slice. Neuroscience. 67:1995;541-550.
7. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta neurol. scand. 165(Suppl.):1996;3-12.
8. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
9. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats: implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Sci. 9:1983;361-380.
10. Chan Palay V. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J. comp. Neurol. 287:1989;373-392.
11. Cole B.J., Robbins T.W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology. 91:1992;458-466.
12. Cole B.J., Robbins T.W. Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology. 7:1992;129-142.
13. Coull J.T., Middleton H.C., Robbins T.W., Sahakian B.J. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology, Berl. 120:1995;322-332.
14. Dunnett S. B. (1992) Operant delayed matching and non-matching to position in rats. In Behavioural Neuroscience: A Practical Approach. (ed. Sahgal A.), pp. 123-136. IRL, Oxford.
15. Eichenbaum H., Otto T., Cohen N.J. Two functional components of the hippocampal memory system. Behav. Brain Sci. 17:1994;449-518.
16. Insausti R., Juottonen K., Soininen H., Insausti A.M., Partanen K., Vainio P., Laakso M., Pitkänen A. MR imaging volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. Am. J. Neuroradiol. 19:1998;659-671.
17. Jäkälä P., Kejonen K., Riekkinen M. and Riekkinen P. J. Jr (1999) Guanfacine, but not clonidine, improves spatial working memory and planning in humans. Neuropsychopharmacology, in press.
18. Jäkälä P., Riekkinen M., Sirviö J., Riekkinen P.J. Guanfacine and clonidine, alpha2-agonists, improve paired associates learning, but not delayed matching to sample, in man. Neuropsychopharmacology. 20:1999;119-130.
19. Kahneman D. and Treisman A. (1984) Changing views of the attention and automaticity. In Varieties of Attention (eds Parasurman R. and Davies D. R.), pp. 29-61. Academic, Orlando, Florida, U.S.A.
20. Katsuki H., Saito H., Satoh M. The involvement of muscarinic, beta-adrenergic and metabotropic glutamate receptros in long-term potentiation in the fimbria-CA3 pathway of the hippocampus. Neurosci. Lett. 142:1992;249-252.
21. Laakso M., Soininen H., Partanen K., Lehtovirta M., Hallikainen M., Hänninen T., Helkala E.-L., Vainio P., Riekkinen P.S. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity and analysis of the incorrectly classified subjects. Neurobiol. Aging. 19:1998;23-31.
22. Mann D.M.A., Yates P.O., Hawkes J. The pathology of the human locus coeruleus. Clin. Neuropath. 2:1983;1-7.
23. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14:1994;2313-2326.
24. Muir J.L., Everitt B.J., Robbins T.W. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology, Berl. 118:1995;82-92.
25. Owen A.M., Sahakian B.J., Semple J., Polkey C.E., Robbins T.W. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia. 33:1995;1-24.
26. Pralong E., Magistretti P.J. Noradrenaline reduces synaptic responses in normal and tottering mouse entorhinal cortex via alpha2-adrenoceptors. Neurosci. Lett. 179:1994;145-148.
27. Pussinen R., Sirviö J. Minor role for alpha1-adrenoceptors in the facilitation of induction and early maintenance of long-term potentiation in the CA1 field of the hippocampus. J. Neurosci. Res. 51:1998;309-315.
28. Riekkinen P.J. Jr., Riekkinen M., Soininen H., Kuikka J., Laakso M., Riekkinen P.S. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease. NeuroReport. 8:1997;1845-1849.
29. Riekkinen M., Soininen H., Riekkinen P.S., Kuikka J., Laakso M., Helkala E.-L., Partanen J., Riekkinen P.J. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease. Neuroscience. 83:1997;471-479.
30. Sahakian B.J., Owen A.M. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J. Roy. Soc. Med. 85:1992;399-402.
31. Sahakian B.J., Owen A.M., Morant N.J., Eagger S.A., Boddington S., Crayton L., Crockford H.A., Crooks M., Hill K., Levy R. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology, Berl. 110:1993;395-401.
32. Sarter M., Bruno J.P., Givens B., Moore H., McGaughy J., McMahon K. Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable. Cogn. Brain Res. 3:1996;329-343.
33. Scheinin H., Kallio A., Koulu M., Scheinin M. Pharmacological effects of medetomidine in humans. Acta vet. scand. 85:1989;145-147.
34. Scheinin M., Kallio A., Koulu M., Viikari J., Scheinin H. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers. Br. J. clin. Pharmac. 24:1987;443-451.
35. Schneider W., Shriffin R.M. Controlled and automatic information processing: 1. Detection, search and attention. Psychol. Rev. 84:1977;1-66.
36. Soininen H., Partanen K., Pitkänen A., Vainio P., Hänninen T., Hallikainen M., Koivisto K., Riekkinen P.S. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology. 44:1994;1660-1668.
37. Wesnes K.A., Simpson P.M., White L., Pinker S., Jertz G., Murphy M., Siegfried K. Cholinesterase inhibition in the scopolamine model of dementia. Ann. N. Y. Acad. Sci. 640:1991;268-271.